Dhvanit Shah is the Founder, President, and CEO at Garuda Therapeutics in Cambridge, Massachusetts. Garuda Therapeutics seeks to create a world that eliminates the dependency on donor or patient cells for blood stem cell transplants. Before becoming a CEO at Garuda Tx, Dhvanit was a principal faculty at Harvard Stem Cell Institute and Associate Member at Broad Institute of MIT and Harvard. Garuda’s foundational discoveries were made at Brigham and Women’s Hospital, where Dhvanit was a principal investigator. Garuda Therapeutics is a poster child of our hospital in how our committed faculty members are poised to taking our bench side discovery to benefits of millions of patients globally.